Several studies have shown that the endothelial vasoactive mediator endothelin-1 is increased in ACS [31,32]; moreover, germline variants of endothelin-1 and endothelial nitric oxide synthase may put patients at increased risk for ACS [33,34]. Here, NOS3 is linked to acute chest syndrome.